Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
BMS Initiates First Round of Layoffs in New Jersey
BioSpace
Wed, 04/24/24 - 09:53 am
Bristol Myers Squibb
New Jersey
layoffs
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
Pharmaphorum
Tue, 04/23/24 - 10:29 am
Novartis
earnings
Giovanni Caforio
Bristol Myers Squibb
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive
Mon, 04/22/24 - 06:06 pm
Bristol Myers Squibb
drug manufacturing
cell therapy
Cellares
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Yahoo/Zacks.com
Sun, 04/21/24 - 10:42 pm
Bristol Myers Squibb
earnings
FDA mandates label updates on CAR-T cancer therapies
Reuters
Thu, 04/18/24 - 10:34 pm
CAR-T
FDA
warning
cancer
Gilead Sciences
Bristol Myers Squibb
2seventybio
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic
Fierce Biotech
Wed, 04/10/24 - 09:52 am
Bristol Myers Squibb
TORL BioTherapeutics
antibody-drug conjugate
funding
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
For biopharma M&A, the best returns come from small deals: analysts
Fierce Pharma
Tue, 04/9/24 - 11:14 am
M&A
Bristol Myers Squibb
AbbVie
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies
Reuters
Sun, 04/7/24 - 04:42 pm
Bristol Myers Squibb
schizophrenia
clinical trials
KarXT
FDA allows expanded use of Bristol Myers' cell therapy for blood cancer
Reuters
Fri, 04/5/24 - 11:40 am
Bristol Myers Squibb
2seventybio
Abecma
cell therapy
BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati
BioSpace
Mon, 04/1/24 - 11:59 am
Bristol Myers Squibb
clinical trials
adagrasib
Krazati
non-small cell lung cancer
Bristol Myers' bowel disease drug fails to meet main goal in late-stage study
Reuters
Thu, 03/28/24 - 05:07 pm
Bristol Myers Squibb
Crohn's Disease
clinical trials
ozanimod
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
Pharma Voice
Wed, 03/27/24 - 10:56 am
Takeda
cliincal trials
TAK-279
Bristol Myers Squibb
clinical trial diversity
psoriasis
Big Pharma CEOs gather in Beijing to show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
China
Pharma CEOs
AstraZeneca
Bayer
Bristol Myers Squibb
GSK
Novartis
Pfizer
Takeda
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma
Clinical Trials Arena
Thu, 03/21/24 - 06:41 pm
bladder cancer
urothelial cancer
Merck
Pfizer
Bristol Myers Squibb
Padcev
Keytruda
Balversa
Opdivo
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Bristol Myers Squibb
immuno-oncology
Opdivo
Yervoy
liver cancer
AstraZeneca
Roche
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Bristol Myers Squibb
CAR-T
CLL
Breyanzi
FDA
JNJ
Carvykti
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
FDA
JNJ
Bristol Myers Squibb
blood cancers
cell therapy
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »